Abstract
This cohort study used Medicaid data to examine trends in the use of and spending for hemophilia pharmaceuticals from 2005 to 2020.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Health Services Accessibility / statistics & numerical data*
-
Hemophilia A / drug therapy*
-
Humans
-
Insurance Coverage / statistics & numerical data
-
Managed Care Programs / standards*
-
Medicaid
-
Patient Satisfaction / statistics & numerical data*
-
Treatment Outcome
-
United States